Diabetes Treatment and Management

SEP 10, 2026 · JOURNAL ARTICLE

CARDIOVASCULAR EFFECTS OF INCRETIN RECEPTOR AGONISTS: BEYOND GLYCEMIC CONTROL

Canadian Journal of Physiology and Pharmacology

A narrative review synthesizing mechanistic evidence and clinical trial data on incretin agonists' cardiovascular effects, providing expert interpretation of existing evidence rather than new primary data.

SEP 10, 2026 · JOURNAL ARTICLE

GUT MICROBIOTA AND PHARMACOLOGICAL TREATMENT RESPONSE IN OBESITY: IMPLICATIONS FOR PERSONALIZED MEDICINE

International Journal of Innovative Technologies in Social Science

A narrative review synthesizing heterogeneous literature to raise mechanistic hypotheses about microbiota–treatment interactions, lacking original data, effect sizes, or a defined study population to support clinical claims.

SEP 9, 2026 · JOURNAL ARTICLE

Impact of GLP-1 receptor agonists on patients with intraductal papillary mucinous neoplasms: Study protocol for a multicentric cohort study

PLOS One

This is a protocol for a retrospective cohort study with an acknowledged small sample size (30–60 patients) and retrospective design; it is designed to generate preliminary data and hypotheses rather than definitive evidence, and no results are yet reported.

SEP 8, 2026 · JOURNAL ARTICLE

Adjuvant therapy in glucagon-like peptide-1 receptor agonist treatment: Enhancement of efficacy and mitigation of adverse events. A review

Consilium Medicum

A narrative review proposing a multifaceted adjuvant therapy algorithm to mitigate GLP-1 agonist adverse events; lacks primary trial evidence and explicitly calls for RCT validation.

SEP 8, 2026 · JOURNAL ARTICLE

Safety, Pharmacokinetics and Pharmacodynamics of the GLP ‐1/ GIP / GCG Receptor Agonist UBT251 Injection: A Randomized, Placebo‐Controlled Phase 1a/1b Study

Diabetes Obesity and Metabolism

First-in-human Phase 1a/1b trial with primary endpoints of safety and tolerability; pharmacodynamic weight loss and metabolic findings are encouraging but uncontrolled comparisons in a small, early-phase study cannot yet support practice changes.

SEP 7, 2026 · JOURNAL ARTICLE

Efficacy, Safety and Clinical Implications of GLP-1 Receptor Agonists for Chronic Weight Management in Patients with or Without Type 2 Diabetes

International Journal of Medical & Pharmaceutical Sciences

A narrative review synthesizing evidence from pivotal trials to evaluate GLP-1 receptor agonists for weight management, offering clinical recommendations rather than reporting original research.

SEP 7, 2026 · JOURNAL ARTICLE

Advances in the management of obesity: non-pharmacological strategies, herbal formulations, current pharmacotherapy, emerging drugs, and future perspectives

Frontiers in Endocrinology

A narrative review synthesising current understanding of obesity management across non-pharmacological, herbal, approved pharmacological and emerging therapeutic strategies, without presenting new primary data or systematic evidence synthesis.

SEP 7, 2026 · JOURNAL ARTICLE

The 2025 AHA/ACC Hypertension Guidelines: Key Updates, Historical Context, and Clinical Implications

Current Cardiology Reports

This is an official multisociety hypertension guideline from the AHA/ACC that synthesizes evidence across populations and provides clinical recommendations for practice.